Literature DB >> 6257933

Partial phosphorylation in vivo of the avian retrovirus pp32 DNA endonuclease.

R D Schiff, D P Grandgenett.   

Abstract

Avian retrovirus pp32, a DNA endonuclease which is structurally related to the avian retrovirus DNA polymerase beta polypeptide, has been demonstrated to be partially phosphorylated in vivo. Unlabeled or [35S]methionine-labeled pp32 from avian sarcoma virus or avian myeloblastosis virus migrated as an electrophoretic doublet on discontinuous sodium dodecyl sulfate-polyacrylamide slab gels. However, pp32 immunoprecipitated from avian sarcoma virus labeled in vivo with [32P]orthophosphoric acid migrated as a single band, which co-electrophoresed with the slower-moving band of the doublet represented by unlabeled or 35S-labeled pp32. The presence of a slower-migrating phosphorylated band in pp32 suggests that the observed electrophoretic heterogeneity of purified pp32 is due to partial phosphorylation. Tryptic peptide analysis of 32P-labeled avian sarcoma virus beta and pp32 demonstrated that all the three labeled peptides in the beta polypeptide were also present in pp32. However, pp32 had one tryptic peptide which was preferentially labeled in comparison to the comigrating peptide found in beta digests, suggesting that phosphorylation may play a role in the processing of pp32 from beta or in the regulation of its associated DNA endonuclease activity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6257933      PMCID: PMC353717     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

Review 1.  Protein phosphorylation.

Authors:  C S Rubin; O M Rosen
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

2.  Phosphorylated and nonphosphorylated forms of avian sarcoma virus polypeptide p19.

Authors:  E Erikson; J S Brugge; R L Erikson
Journal:  Virology       Date:  1977-07-01       Impact factor: 3.616

3.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The beta subunit of the DNA polymerase of avian sarcoma virus strain B77 is a phosphoprotein.

Authors:  A Hizi; W K Joklik
Journal:  Virology       Date:  1977-05-15       Impact factor: 3.616

6.  Identification of an avian oncovirus polyprotein in uninfected chick cells.

Authors:  R Eisenman; R Shaikh; W S Mason
Journal:  Cell       Date:  1978-05       Impact factor: 41.582

7.  Protein kinase and its regulatory effect on reverse transcriptase activity of Rous sarcoma virus.

Authors:  S G Lee; M V Miceli; R A Jungmann; P P Hung
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

8.  Influence of phosphate on activity and stability of reverse transcriptase from avian myeloblastosis virus.

Authors:  C M Tsiapalis; G E Houts; J W Beard
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

9.  Proteins of Rous-associated virus 61, an avian retrovirus: common precursor for glycoproteins gp85 and gp35 and use of pactamycin to map translational order of proteins in the gag, pol, and env genes.

Authors:  D J Shealy; R R Rueckert
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

10.  Reverse transcriptase of RNA tumor viruses. V. In vitro proteolysis of reverse transcriptase from avian myeloblastosis virus and isolation of a polypeptide manifesting only RNase H activity.

Authors:  M H Lai; I M Verma
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

View more
  11 in total

1.  Phosphorylation of the avian retrovirus integration protein and proteolytic processing of its carboxyl terminus.

Authors:  R Horton; S R Mumm; D P Grandgenett
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

2.  Nuclease mechanism of the avian retrovirus pp32 endonuclease.

Authors:  D P Grandgenett; A C Vora; R Swanstrom; J C Olsen
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

3.  Genetic evidence that the avian retrovirus DNA endonuclease domain of pol is necessary for viral integration.

Authors:  T P Quinn; D P Grandgenett
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

4.  Avian sarcoma and leukosis virus pol-endonuclease recognition of the tandem long terminal repeat junction: minimum site required for cleavage is also required for viral growth.

Authors:  D Cobrinik; R Katz; R Terry; A M Skalka; J Leis
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

5.  The major site of phosphorylation within the Rous sarcoma virus MA protein is not required for replication.

Authors:  T D Nelle; M F Verderame; J Leis; J W Wills
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

6.  The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration.

Authors:  M Katzman; R A Katz; A M Skalka; J Leis
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

7.  Avian retrovirus pp32 DNA-binding protein. I. Recognition of specific sequences on retrovirus DNA terminal repeats.

Authors:  T K Misra; D P Grandgenett; J T Parsons
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

8.  Avian retrovirus pp32 DNA endonuclease is phosphorylated on Ser in the carboxyl-terminal region.

Authors:  R Horton; S Mumm; D P Grandgenett
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

9.  Properties of avian sarcoma-leukosis virus pp32-related pol-endonucleases produced in Escherichia coli.

Authors:  R Terry; D A Soltis; M Katzman; D Cobrinik; J Leis; A M Skalka
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

10.  v-Src enhances phosphorylation at Ser-282 of the Rous sarcoma virus integrase.

Authors:  S R Mumm; R Horton; D P Grandgenett
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.